|
【结 构 式】 
|
【分子编号】12989 【品名】4-Bromo-2-methyl-2-butene; 1-Bromo-3-methyl-2-butene 【CA登记号】870-63-3 |
【 分 子 式 】C5H9Br 【 分 子 量 】149.03046 【元素组成】C 40.3% H 6.09% Br 53.62% |
合成路线1
该中间体在本合成路线中的序号：(IV)An enantioselective total synthesis of chloride (MOM-Cl) and NaH in THF gives the methoxymethyl ether (II), which is methylated with n-BuLi and methyl iodide in THF yielding the 6-methyl derivative (III). The condensation of (III) with 3-methyl-2-butenyl bromide (IV) by means of s-BuLi in THF affords compound (V), which is deprotected with LiBF4 and TMSCl in acetonitrile to give the phenol (VI). Methylation of (VI) with dimethyl sulfate and K2CO3 in refluxing acetone provides the ether (VII), which is hydroxylated at the terminal methyl group with SeO2 and tert-butyl hydroperoxide (TBHP) in dichloromethane giving alcohol (VIII). The reaction of (VIII) with methanesulfonyl chloride and then with LiBr affords the corresponding alkenyl bromide (IX), which is condensed with methyl acetoacetate (X) by means of NaH and n-BuLi in THF providing the ketoester (XI).
| 【1】 Ye, X.-Y.; Yang, D.; Xu, M.; Enantioselective total synthesis of (-)-triptolide, (-)-triptonide, (+)-triptophenolide, and (+)-triptoquinomide. J Org Chem 2000, 65, 7, 2208. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 37653 | 2-isopropylphenol | 88-69-7 | C9H12O | 详情 | 详情 |
| (II) | 37654 | 1-isopropyl-2-(methoxymethoxy)benzene; (2-isopropylphenoxy)methyl methyl ether | C11H16O2 | 详情 | 详情 | |
| (III) | 37655 | 1-isopropyl-2-(methoxymethoxy)-3-methylbenzene; (2-isopropyl-6-methylphenoxy)methyl methyl ether | C12H18O2 | 详情 | 详情 | |
| (IV) | 12989 | 4-Bromo-2-methyl-2-butene; 1-Bromo-3-methyl-2-butene | 870-63-3 | C5H9Br | 详情 | 详情 |
| (V) | 37656 | 1-isopropyl-2-(methoxymethoxy)-3-(4-methyl-3-pentenyl)benzene; [2-isopropyl-6-(4-methyl-3-pentenyl)phenoxy]methyl methyl ether | C17H26O2 | 详情 | 详情 | |
| (VI) | 37657 | 2-isopropyl-6-(4-methyl-3-pentenyl)phenol | C15H22O | 详情 | 详情 | |
| (VII) | 37658 | 1-isopropyl-2-methoxy-3-(4-methyl-3-pentenyl)benzene; 2-isopropyl-6-(4-methyl-3-pentenyl)phenyl methyl ether | C16H24O | 详情 | 详情 | |
| (VIII) | 37659 | (E)-5-(3-isopropyl-2-methoxyphenyl)-2-methyl-2-penten-1-ol | C16H24O2 | 详情 | 详情 | |
| (IX) | 37660 | 2-[(E)-5-bromo-4-methyl-3-pentenyl]-6-isopropylphenyl methyl ether; 1-[(E)-5-bromo-4-methyl-3-pentenyl]-3-isopropyl-2-methoxybenzene | C16H23BrO | 详情 | 详情 | |
| (X) | 11791 | methyl 3-oxobutanoate; Methyl acetoacetate | 105-45-3 | C5H8O3 | 详情 | 详情 |
| (XI) | 35414 | methyl (E)-9-(3-isopropyl-2-methoxyphenyl)-6-methyl-3-oxo-6-nonenoate | C21H30O4 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号：(II)The condensation of verbenone (I) with 1-bromo-3-methyl-2-butene (II) by means of t-BuOK in DME, followed by ozonolysis of the aliphatic double bond gives acetaldehyde (III), which is isomerized with UV light in methanol to the chrysanthenone derivative (IV). The condensation of (IV) with ethyl propynoate (V) by means of LDA in THF, followed by silylation with TMSCl affords the silylated 4-hydroxy-2-pentynoate (VI), which is cyclized by means of Me2CuLi in ethyl ether giving the methanonaphthalene derivative (VII). The oxidation of the secondary OH group of (VII) with Dess Martin periodinane (DMP) yields the ketoester (VIII), which is hydroxylated with Davis' oxaziridine to the ketonic dihydroxyester (IX). The reduction of the ester group of (IX) with LiAlH4 in ethyl ether affords the tetrahydroxy compound (X), which is protected by silylation with TBDMS-Cl and imidazole and ketalization with PPTS and 2-methoxypropene providing the silylated acetonide (XI). The rearrangement of (XI) by means of MCPBA, followed by silylation with Tips-OTf gives (XII) with the A-B-bicycle of Taxol. The hydroxylation of (XII) with t-BuOK and oxygen, followed by reduction of its ketonic group with NaBH4 yields the trihydroxy compound (XIII), which is stereoselectively reduced with H2 and Crabtree catalyst, silylated with TMSCl and treated with triphosgene to afford the cyclic carbonate (XIV). The oxidation of (XIV) with pyridinium chlorochromate (PCC) in dichloromethane gives the carbaldehyde (XV), which is condensed with methoxymethyl(triphenyl)phosphorane to yield the acetaldehyde derivative (XVI). The selective silylation of (XVI) with Tes-Cl, followed by oxidation of the remaining secondary OH group with Dess Martin periodinane (DMP) and methylenation acetaldehyde CH2 group with Me2N-CH2-I affords the substituted propenoic aldehyde (XVII).
| 【1】 Wender, P.A.; et al.; The pinene path to taxanes. 5. Stereocontrolled synthesis of a versatile taxane precursor. J Am Chem Soc 1997, 119, 11, 2755. |
| 【2】 Wender, P.A.; et al.; The pinene path to taxanes. 6. Concise stereocontrolled synthesis of Taxol. J Am Chem Soc 1997, 119, 11, 2757. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| 17354 | isopropenyl methyl ether; 2-methoxy-1-propene | 116-11-0 | C4H8O | 详情 | 详情 | |
| 40589 | methyl (triphenylphosphoranylidene)methyl ether; (methoxymethylene)(triphenyl)phosphorane | C20H19OP | 详情 | 详情 | ||
| 40590 | iodo-N,N-dimethylmethanamine; N-(iodomethyl)-N,N-dimethylamine | C3H8IN | 详情 | 详情 | ||
| (I) | 35330 | 4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-one | 1196-01-6 | C10H14O | 详情 | 详情 |
| (II) | 12989 | 4-Bromo-2-methyl-2-butene; 1-Bromo-3-methyl-2-butene | 870-63-3 | C5H9Br | 详情 | 详情 |
| (III) | 35331 | 2-(2,6,6-trimethyl-4-oxobicyclo[3.1.1]hept-2-en-3-yl)acetaldehyde | C12H16O2 | 详情 | 详情 | |
| (IV) | 35332 | 2-(2,6,6-trimethyl-7-oxobicyclo[3.1.1]hept-2-en-1-yl)acetaldehyde | C12H16O2 | 详情 | 详情 | |
| (V) | 35333 | ethyl propiolate | 623-47-2 | C5H6O2 | 详情 | 详情 |
| (VI) | 35334 | ethyl 5-(2,6,6-trimethyl-7-oxobicyclo[3.1.1]hept-2-en-1-yl)-4-[(trimethylsilyl)oxy]-2-pentynoate | C20H30O4Si | 详情 | 详情 | |
| (VII) | 35335 | ethyl (6R)-3,6-dihydroxy-4,10,11,11-tetramethyltricyclo[5.3.1.0(1,6)]undeca-4,9-diene-5-carboxylate | C18H26O4 | 详情 | 详情 | |
| (VIII) | 35336 | ethyl (6R)-6-hydroxy-4,10,11,11-tetramethyl-3-oxotricyclo[5.3.1.0(1,6)]undeca-4,9-diene-5-carboxylate | C18H24O4 | 详情 | 详情 | |
| (IX) | 35337 | ethyl (2S,6R)-2,6-dihydroxy-4,10,11,11-tetramethyl-3-oxotricyclo[5.3.1.0(1,6)]undeca-4,9-diene-5-carboxylate | C18H24O5 | 详情 | 详情 | |
| (X) | 35338 | (2S,3S,6S)-5-(hydroxymethyl)-4,10,11,11-tetramethyltricyclo[5.3.1.0(1,6)]undeca-4,9-diene-2,3,6-triol | C16H24O4 | 详情 | 详情 | |
| (XI) | 35339 | (2S,6S,9S)-8-([[tert-butyl(dimethyl)silyl]oxy]methyl)-4,4,7,13,14,14-hexamethyl-3,5-dioxatetracyclo[8.3.1.0(1,9).0(2,6)]tetradeca-7,12-dien-9-ol | C25H42O4Si | 详情 | 详情 | |
| (XII) | 35340 | (2S,6S,12S)-8-([[tert-butyl(dimethyl)silyl]oxy]methyl)-4,4,7,13,14,14-hexamethyl-12-[(triisopropylsilyl)oxy]-3,5-dioxatricyclo[8.3.1.0(2,6)]tetradeca-1(13),7-dien-9-one | C34H62O5Si2 | 详情 | 详情 | |
| (XIII) | 35341 | (2S,6S,9S,10S,12S)-8-(hydroxymethyl)-4,4,7,13,14,14-hexamethyl-12-[(triisopropylsilyl)oxy]-3,5-dioxatricyclo[8.3.1.0(2,6)]tetradeca-1(13),7-diene-9,10-diol | C28H50O6Si | 详情 | 详情 | |
| (XIV) | 35342 | (1S,5S,6S,7S,8S,12S,15S)-7,10,10,14,17,17-hexamethyl-15-[(triisopropylsilyl)oxy]-6-[[(trimethylsilyl)oxy]methyl]-2,4,9,11-tetraoxatetracyclo[11.3.1.0(1,5).0(8,12)]heptadec-13-en-3-one | C32H58O7Si2 | 详情 | 详情 | |
| (XV) | 35343 | (1S,5S,6R,7S,8S,12S,15S)-7,10,10,14,17,17-hexamethyl-3-oxo-15-[(triisopropylsilyl)oxy]-2,4,9,11-tetraoxatetracyclo[11.3.1.0(1,5).0(8,12)]heptadec-13-ene-6-carbaldehyde | C29H48O7Si | 详情 | 详情 | |
| (XVI) | 35344 | 2-[(1S,5S,6R,7S,8S,9S,12S)-8,9-dihydroxy-7,11,14,14-tetramethyl-3-oxo-12-[(triisopropylsilyl)oxy]-2,4-dioxatricyclo[8.3.1.0(1,5)]tetradec-10-en-6-yl]acetaldehyde | C27H46O7Si | 详情 | 详情 | |
| (XVII) | 35345 | 2-[(1S,5S,6S,7S,8S,12S)-7,11,14,14-tetramethyl-3,9-dioxo-8-[(triethylsilyl)oxy]-12-[(triisopropylsilyl)oxy]-2,4-dioxatricyclo[8.3.1.0(1,5)]tetradec-10-en-6-yl]acrylaldehyde | C34H58O7Si2 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号：(I)The condensation of thiophenol (II) with 3-methyl-2-butenyl bromide (I) by means of NaOH in refluxing acetone gives 3-methyl-2-butenyl(phenyl)sulfide (III), which is cyclized by means of P2O5 and H3PO4 in refluxing benzene to yield 4,4-dimethyl-3,4-dihydro-1H-1-benzothiopyran (IV). The acylation of (IV) with acetyl chloride catalyzed by SnCl4 in benzene affords the corresponding 6-acetyl derivative (V), which by dehydration with lithium diisopropylamide and diethyl chlorophosphate in THF is converted into 6-ethynyl-4,4-dimethyl-3,4-dihydro-2H-1-benzothiopyran (VI). Finally, this compound is condensed with ethyl 6-chloropyridine-3-carboxylate (VII) by means of butyllithium in THF. The ester (VII) is obtained by esterification of the corresponding acid (VIII) with ethanol by means of dicyclohexylcarbodiimide (DCC) and dimethylaminopyridine (DMAP).
| 【1】 Ngo, J.; Leeson, P.A.; Castaner, J.; Tazarotene. Drugs Fut 1997, 22, 3, 249. |
| 【2】 Chandraratna, R.A.S. (Allergan, Inc.); Disubstd. acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity. EP 0284288; JP 88255277; JP 95324085 . |
| 【3】 Chandraratna, R.A.S. (Allergan, Inc.); Disubstd. acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity. US 5089509 . |
| 【4】 Chandraratna, R.A. (Allergan, Inc.); Disubstd. acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity. WO 9611686 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 12989 | 4-Bromo-2-methyl-2-butene; 1-Bromo-3-methyl-2-butene | 870-63-3 | C5H9Br | 详情 | 详情 |
| (II) | 12951 | Benzenethiol; Phenylmercaptan; Phenylhydrosulfide | 108-98-5 | C6H6S | 详情 | 详情 |
| (III) | 12991 | 1-[(3-Methyl-2-butenyl)sulfanyl]benzene; 3-Methyl-2-butenyl phenyl sulfide | C11H14S | 详情 | 详情 | |
| (IV) | 12992 | 4,4-Dimethylthiochromane | C11H14S | 详情 | 详情 | |
| (V) | 12993 | 1-(4,4-Dimethyl-3,4-dihydro-2H-thiochromen-6-yl)-1-ethanone | C13H16OS | 详情 | 详情 | |
| (VI) | 12994 | 6-Ethynyl-4,4-dimethylthiochromane | C13H14S | 详情 | 详情 | |
| (VII) | 12995 | ethyl 6-chloronicotinate | 49608-01-7 | C8H8ClNO2 | 详情 | 详情 |
| (VIII) | 12996 | 6-Chloronicotinic acid | 5326-23-8 | C6H4ClNO2 | 详情 | 详情 |
合成路线4
该中间体在本合成路线中的序号：(VIII)The reaction of S-methylisothiourea (I) with Boc2O by means of NaHCO3 gives the N-Boc protected isothiourea (II), which is condensed with 1,4-butanediamine (III) in hot THF to yield the guanidine derivative (IV). The acylation of the amino group of (IV) with 3,4-dimethoxycinnamoyl chloride (V) with THF/DMF affords the corresponding amide (VI), which is deprotected with TFA to provide N-(4-guanidinobutyl)-3,4-dimethoxycinnamamide (VII). Finally, the guanidino group of (VII) is alkylated with 3-methyl-2-butenyl bromide (VIII) catalyzed by DMAP in THF to provide the target, caracasanamide.
| 【1】 Delle Monache, G.; Delle Monache, F.; Botta, B.; Bonnevaux Castillo, S.; Espinal, R.; De Luca, C.; Carmignani, M. (Consiglio Nazionale delle Ricerche); Guanidine derivs. having hypotensive activity, compsn. containing them, and process for obtaining them. EP 0330629; JP 1990003661; US 5059624 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 10272 | [[Amino(imino)methyl]sulfanyl]methane | 2986-19-8 | C2H6N2S | 详情 | 详情 |
| (II) | 22345 | tert-butyl (E)-[(tert-butoxycarbonyl)amino](methylsulfanyl)methylidenecarbamate | C12H22N2O4S | 详情 | 详情 | |
| (III) | 42070 | 1,4-butanediamine; 4-aminobutylamine | 110-60-1 | C4H12N2 | 详情 | 详情 |
| (IV) | 53109 | tert-butyl (Z)-[(4-aminobutyl)amino][(tert-butoxycarbonyl)amino]methylidenecarbamate | n/a | C15H30N4O4 | 详情 | 详情 |
| (V) | 33601 | (E)-3-(3,4-dimethoxyphenyl)-2-propenoyl chloride | C11H11ClO3 | 详情 | 详情 | |
| (VI) | 53110 | tert-butyl (Z)-[(tert-butoxycarbonyl)amino][(4-{[(E)-3-(3,4-dimethoxyphenyl)-2-propenoyl]amino}butyl)amino]methylidenecarbamate | n/a | C26H40N4O7 | 详情 | 详情 |
| (VII) | 53111 | (E)-N-(4-{[amino(imino)methyl]amino}butyl)-3-(3,4-dimethoxyphenyl)-2-propenamide | n/a | C16H24N4O3 | 详情 | 详情 |
| (VIII) | 12989 | 4-Bromo-2-methyl-2-butene; 1-Bromo-3-methyl-2-butene | 870-63-3 | C5H9Br | 详情 | 详情 |
合成路线5
该中间体在本合成路线中的序号：(XI)The condensation of 4-O-benzyl-L-tyrosine methyl ester (I) with 4-methoxybenzaldehyde (II) in methanol gives the imine (III), which is oxidized with MCPBA yielding the oxaziridine (IV). The reaction of (IV) with NH2OH affords the 4-O-benzyl-N-hydroxy-L-tyrosine methyl ester (V), which is condensed with cyclohexane-1,4-dione monobutyleneketal (VI) in ethanol giving the imine oxide (VII). The cyclization of (VII) with ethyl acrylate (VIII) in refluxing toluene yields the spiranic isoxazolidine (IX). The hydrogenolysis of the O-N bond of (IX) with H2 over Pd/C, followed by lactam formation by means of AcOH affords the spiranic hydroxypyrrolidinone (X), which is alkylated at the phenolic OH with 3-methyl-2-butenyl bromide (XI) and Cs2CO3 in hot acetone providing the phenolic ether (XII). The reaction of (XII) with tosyl chloride, TEA and DMAP gives the tosylate (XIII), which is treated with sodium azide in DMF to affords the azide (XIV). The reduction of (XIV) with LiAlH4 followed by reductive methylation of the resulting amine with formic acetic anhydride and LiAlH4 provides the methyl-amino derivative (XV).
| 【1】 Lin, H.; Snider, B.B.; Biomimeric total syntheses of (-)-TAN1251A, (+)-TAN1251B, (+)-TAN1251C, and (+)-TAN1251D. Org Lett 2000, 2, 5, 643. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 36917 | methyl (2S)-2-amino-3-[4-(benzyloxy)phenyl]propanoate | C17H19NO3 | 详情 | 详情 | |
| (II) | 27251 | 4-methoxybenzaldehyde; Anisicaldehyde; p-anisaldehyde | 123-11-5 | C8H8O2 | 详情 | 详情 |
| (III) | 36918 | methyl (2S)-3-[4-(benzyloxy)phenyl]-2-[[(E)-(4-methoxyphenyl)methylidene]amino]propanoate | C25H25NO4 | 详情 | 详情 | |
| (IV) | 36919 | methyl (2S)-3-[4-(benzyloxy)phenyl]-2-[3-(4-methoxyphenyl)-1,2-oxaziridin-2-yl]propanoate | C25H25NO5 | 详情 | 详情 | |
| (V) | 36920 | methyl (2S)-3-[4-(benzyloxy)phenyl]-2-(hydroxyamino)propanoate | C17H19NO4 | 详情 | 详情 | |
| (VI) | 36921 | 7,12-dioxaspiro[5.6]dodecan-3-one | C10H16O3 | 详情 | 详情 | |
| (VII) | 36922 | [(1S)-1-[4-(benzyloxy)benzyl]-2-methoxy-2-oxoethyl](7,12-dioxaspiro[5.6]dodec-3-ylidene)ammoniumolate | C27H33NO6 | 详情 | 详情 | |
| (VIII) | 10164 | ethyl acrylate | 140-88-5 | C5H8O2 | 详情 | 详情 |
| (IX) | 36923 | ethyl (3R)-1-[(1S)-1-[4-(benzyloxy)benzyl]-2-methoxy-2-oxoethyl]-2,9,14-trioxa-1-azadispiro[4.2.6.2]hexadecane-3-carboxylate | C32H41NO8 | 详情 | 详情 | |
| (X) | 36924 | methyl (2S)-2-[(3R)-3-hydroxy-2-oxo-9,14-dioxa-1-azadispiro[4.2.6.2]hexadec-1-yl]-3-(4-hydroxyphenyl)propanoate | C23H31NO7 | 详情 | 详情 | |
| (XI) | 12989 | 4-Bromo-2-methyl-2-butene; 1-Bromo-3-methyl-2-butene | 870-63-3 | C5H9Br | 详情 | 详情 |
| (XII) | 36925 | methyl (2S)-2-[(3R)-3-hydroxy-2-oxo-9,14-dioxa-1-azadispiro[4.2.6.2]hexadec-1-yl]-3-[4-[(3-methyl-2-butenyl)oxy]phenyl]propanoate | C28H39NO7 | 详情 | 详情 | |
| (XIII) | 36926 | methyl (2S)-3-[4-[(3-methyl-2-butenyl)oxy]phenyl]-2-((3R)-3-[[(4-methylphenyl)sulfonyl]oxy]-2-oxo-9,14-dioxa-1-azadispiro[4.2.6.2]hexadec-1-yl)propanoate | C35H45NO9S | 详情 | 详情 | |
| (XIV) | 36927 | methyl (2S)-2-[(3S)-3-azido-2-oxo-9,14-dioxa-1-azadispiro[4.2.6.2]hexadec-1-yl]-3-[4-[(3-methyl-2-butenyl)oxy]phenyl]propanoate | C28H38N4O6 | 详情 | 详情 | |
| (XV) | 36928 | methyl (2S)-2-[(3S)-3-(methylamino)-9,14-dioxa-1-azadispiro[4.2.6.2]hexadec-1-yl]-3-[4-[(3-methyl-2-butenyl)oxy]phenyl]propanoate | C29H44N2O5 | 详情 | 详情 |
合成路线6
该中间体在本合成路线中的序号：(XI)The condensation of 4-O-benzyl-L-tyrosine methyl ester (I) with 4-methoxybenzaldehyde (II) in methanol gives the imine (III), which is oxidized with MCPBA yielding the oxaziridine (IV). The reaction of (IV) with NH2OH affords the 4-O-benzyl-N-hydroxy-L-tyrosine methyl ester (V), which is condensed with cyclohexane-1,4-dione monobutyleneketal (VI) in ethanol giving the imine oxide (VII). The cyclization of (VII) with ethyl acrylate (VIII) in refluxing toluene yields the spiranic isoxazolidine (IX). The hydrogenolysis of the O-N bond of (IX) with H2 over Pd/C, followed by lactam formation by means of AcOH affords the spiranic hydroxypyrrolidinone (X), which is alkylated at the phenolic OH with 3-methyl-2-butenyl bromide (XI) and Cs2CO3 in hot acetone providing the phenolic ether (XII). The reaction of (XII) with tosyl chloride, TEA and DMAP gives the tosylate (XIII), which is treated with sodium azide in DMF to affords the azide (XIV). The reduction of (XIV) with LiAlH4 followed by reductive methylation of the resulting amine with formic acetic anhydride and LiAlH4 provides the methylamino derivative.
| 【1】 Lin, H.; Snider, B.B.; Biomimeric total syntheses of (-)-TAN1251A, (+)-TAN1251B, (+)-TAN1251C, and (+)-TAN1251D. Org Lett 2000, 2, 5, 643. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 36917 | methyl (2S)-2-amino-3-[4-(benzyloxy)phenyl]propanoate | C17H19NO3 | 详情 | 详情 | |
| (II) | 27251 | 4-methoxybenzaldehyde; Anisicaldehyde; p-anisaldehyde | 123-11-5 | C8H8O2 | 详情 | 详情 |
| (III) | 36918 | methyl (2S)-3-[4-(benzyloxy)phenyl]-2-[[(E)-(4-methoxyphenyl)methylidene]amino]propanoate | C25H25NO4 | 详情 | 详情 | |
| (IV) | 36919 | methyl (2S)-3-[4-(benzyloxy)phenyl]-2-[3-(4-methoxyphenyl)-1,2-oxaziridin-2-yl]propanoate | C25H25NO5 | 详情 | 详情 | |
| (V) | 36920 | methyl (2S)-3-[4-(benzyloxy)phenyl]-2-(hydroxyamino)propanoate | C17H19NO4 | 详情 | 详情 | |
| (VI) | 36921 | 7,12-dioxaspiro[5.6]dodecan-3-one | C10H16O3 | 详情 | 详情 | |
| (VII) | 36922 | [(1S)-1-[4-(benzyloxy)benzyl]-2-methoxy-2-oxoethyl](7,12-dioxaspiro[5.6]dodec-3-ylidene)ammoniumolate | C27H33NO6 | 详情 | 详情 | |
| (VIII) | 10164 | ethyl acrylate | 140-88-5 | C5H8O2 | 详情 | 详情 |
| (IX) | 36923 | ethyl (3R)-1-[(1S)-1-[4-(benzyloxy)benzyl]-2-methoxy-2-oxoethyl]-2,9,14-trioxa-1-azadispiro[4.2.6.2]hexadecane-3-carboxylate | C32H41NO8 | 详情 | 详情 | |
| (X) | 36924 | methyl (2S)-2-[(3R)-3-hydroxy-2-oxo-9,14-dioxa-1-azadispiro[4.2.6.2]hexadec-1-yl]-3-(4-hydroxyphenyl)propanoate | C23H31NO7 | 详情 | 详情 | |
| (XI) | 12989 | 4-Bromo-2-methyl-2-butene; 1-Bromo-3-methyl-2-butene | 870-63-3 | C5H9Br | 详情 | 详情 |
| (XII) | 36925 | methyl (2S)-2-[(3R)-3-hydroxy-2-oxo-9,14-dioxa-1-azadispiro[4.2.6.2]hexadec-1-yl]-3-[4-[(3-methyl-2-butenyl)oxy]phenyl]propanoate | C28H39NO7 | 详情 | 详情 | |
| (XIII) | 36926 | methyl (2S)-3-[4-[(3-methyl-2-butenyl)oxy]phenyl]-2-((3R)-3-[[(4-methylphenyl)sulfonyl]oxy]-2-oxo-9,14-dioxa-1-azadispiro[4.2.6.2]hexadec-1-yl)propanoate | C35H45NO9S | 详情 | 详情 | |
| (XIV) | 36927 | methyl (2S)-2-[(3S)-3-azido-2-oxo-9,14-dioxa-1-azadispiro[4.2.6.2]hexadec-1-yl]-3-[4-[(3-methyl-2-butenyl)oxy]phenyl]propanoate | C28H38N4O6 | 详情 | 详情 | |
| (XV) | 36928 | methyl (2S)-2-[(3S)-3-(methylamino)-9,14-dioxa-1-azadispiro[4.2.6.2]hexadec-1-yl]-3-[4-[(3-methyl-2-butenyl)oxy]phenyl]propanoate | C29H44N2O5 | 详情 | 详情 |
合成路线7
该中间体在本合成路线中的序号：(III)The diazonium salt prepared from 2-amino-5-nitrophenol (I) was subjected to Sandmeyer reaction in the presence of HCl and CuCl to afford the chlorophenol derivative (II). Subsequent alkylation of phenol (II) with prenyl bromide (III) produced ether (IV). Amine (V) was then obtained by reduction of the nitro group of (IV) employing iron powder in the presence of HCl.
| 【1】 Brouwer, W.G.; Osika, E.M.; Pierce, B.J. (Uniroyal Chemical Company, Inc.); Furan- and thiophenecarbothioamide derivs., their preparation and their use as inhibitors of the replication of HIV-1 and HIV-1 mutants. EP 0874839; JP 1999504657; US 5696151; WO 9719940 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 33067 | 2-amino-5-nitrophenol | 121-88-0 | C6H6N2O3 | 详情 | 详情 |
| (II) | 56028 | 2-chloro-5-nitrophenol | 619-10-3 | C6H4ClNO3 | 详情 | 详情 |
| (III) | 12989 | 4-Bromo-2-methyl-2-butene; 1-Bromo-3-methyl-2-butene | 870-63-3 | C5H9Br | 详情 | 详情 |
| (IV) | 56029 | 1-chloro-2-[(3-methyl-2-butenyl)oxy]-4-nitrobenzene; 2-chloro-5-nitrophenyl 3-methyl-2-butenyl ether | C11H12ClNO3 | 详情 | 详情 | |
| (V) | 56030 | 4-chloro-3-[(3-methyl-2-butenyl)oxy]phenylamine; 4-chloro-3-[(3-methyl-2-butenyl)oxy]aniline | C11H14ClNO | 详情 | 详情 |
合成路线8
该中间体在本合成路线中的序号：(IV)The reductocondensation of 4-benzyloxyaniline (I) with 1-(tert-butoxycarbonyl)piperidin-4-one (II) by means of NaBH(OAc)2 in dichloromethane gives N-(4-benzyloxyphenyl)-N-[1-(tert-butoxycarbonyl)piperidin-4-yl]amine (III), which is alkylated with 3-methyl-2-butenyl bromide (IV) by means of DIEA in THF yielding the tertiary amine (V). The deprotection of (V) with TFA in dichloromethane affords the piperidine (VI), which is condensed with N-(tert-butoxycarbonyl)-L-leucine (VII) by means of HBTU and DIEA in DMF to provide the intermediate (VIII). Finally, (VIII) is deprotected with TFA in dichloromethane.
| 【1】 Ryder, T.R.; Hu, L.-Y.; Rafferty, M.F.; et al.; Synthesis of a series of 4-benzyloxyaniline analogues as neuronal N-type calcium channel blockers with improved anticonvulsant and analgesic properties. J Med Chem 1999, 42, 20, 4239. |
| 【2】 Rafferty, M.F.; Ryder, T.R.; Hu, L.-Y. (Pfizer Inc.); Aniline derivs. as calcium channel blockers. WO 9907689 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 22460 | 4-(benzyloxy)aniline; 4-(benzyloxy)phenylamine | C13H13NO | 详情 | 详情 | |
| (II) | 18620 | tert-butyl 4-oxo-1-piperidinecarboxylate;BOC-Piperidone;N-(tert-Butoxycarbonyl)-4-piperidone; N-Boc-4-piperidone | 79099-07-3 | C10H17NO3 | 详情 | 详情 |
| (III) | 38230 | tert-butyl 4-[4-(benzyloxy)anilino]-1-piperidinecarboxylate | C23H30N2O3 | 详情 | 详情 | |
| (IV) | 12989 | 4-Bromo-2-methyl-2-butene; 1-Bromo-3-methyl-2-butene | 870-63-3 | C5H9Br | 详情 | 详情 |
| (V) | 38231 | tert-butyl 4-[4-(benzyloxy)(3-methyl-2-butenyl)anilino]-1-piperidinecarboxylate | C28H38N2O3 | 详情 | 详情 | |
| (VI) | 38232 | N-[4-(benzyloxy)phenyl]-N-(3-methyl-2-butenyl)-N-(4-piperidinyl)amine; N-[4-(benzyloxy)phenyl]-N-(3-methyl-2-butenyl)-4-piperidinamine | C23H30N2O | 详情 | 详情 | |
| (VII) | 23663 | (2S)-2-[(tert-butoxycarbonyl)amino]-4-methylpentanoic acid；N-Boc-L-leucine | C11H21NO4 | 详情 | 详情 | |
| (VIII) | 38233 | tert-butyl (1S)-1-([4-[4-(benzyloxy)(3-methyl-2-butenyl)anilino]-1-piperidinyl]carbonyl)-3-methylbutylcarbamate | C34H49N3O4 | 详情 | 详情 |
合成路线9
该中间体在本合成路线中的序号：(IX)The reaction of N-(tert-butoxycarbonyl)-L-leucine (I) with N,O-dimethylhydroxylamine and HBTU in DMF gives the corresponding methoxyamide (II), which is reduced with LiAlH4 in ethyl ether yielding the aldehyde (III). The reductocondensation of (III) with the piperidine (IV) by means of sodium triacetoxyborohydride in dichloromethane affords the protected adduct (V), which is finally deprotected with TFA in dichloromethane. The intermediate piperidine (IV) has been obtained as follows: The reductocondensation of the piperidinone (VI) with 4-(benzyloxy)aniline (VII) by means of sodium triacetoxyborohydride in dichloromethane gives the secondary amine (VIII), which is alkylated with 3-methyl-2-butenyl bromide (IX) and DIPEA in THF yielding the protected piperidine (IX). Finally, this compound is deprotected with TFA in dichloromethane to afford the target intermediate (IV).
| 【1】 Siebers, K.M.; Hu, L.-Y.; Rafferty, M.F.; et al.; Neuronal N-type calcium channel blocker: Structure-activity relationship of a series of (S)-2-amino-1(4-[(4-benzyloxy-phenyl)-(3-methyl-but-2-enyl)-amino]-piperidin-1-yl)-4-methyl-pentan-1-one analogs. 219th ACS Natl Meet (March 26 2000, San Francisco) 2000, Abst MEDI 259. |
| 【2】 Rafferty, M.F.; Ryder, T.R.; Hu, L.-Y. (Pfizer Inc.); Aniline derivs. as calcium channel blockers. WO 9907689 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 23663 | (2S)-2-[(tert-butoxycarbonyl)amino]-4-methylpentanoic acid；N-Boc-L-leucine | C11H21NO4 | 详情 | 详情 | |
| (II) | 40395 | tert-butyl (1S)-1-[[methoxy(methyl)amino]carbonyl]-3-methylbutylcarbamate | C13H26N2O4 | 详情 | 详情 | |
| (III) | 27058 | tert-butyl (1S)-1-formyl-3-methylbutylcarbamate | C11H21NO3 | 详情 | 详情 | |
| (IV) | 38232 | N-[4-(benzyloxy)phenyl]-N-(3-methyl-2-butenyl)-N-(4-piperidinyl)amine; N-[4-(benzyloxy)phenyl]-N-(3-methyl-2-butenyl)-4-piperidinamine | C23H30N2O | 详情 | 详情 | |
| (V) | 40394 | tert-butyl (1S)-1-([4-[4-(benzyloxy)(3-methyl-2-butenyl)anilino]-1-piperidinyl]methyl)-3-methylbutylcarbamate | C34H51N3O3 | 详情 | 详情 | |
| (VI) | 18620 | tert-butyl 4-oxo-1-piperidinecarboxylate;BOC-Piperidone;N-(tert-Butoxycarbonyl)-4-piperidone; N-Boc-4-piperidone | 79099-07-3 | C10H17NO3 | 详情 | 详情 |
| (VII) | 22460 | 4-(benzyloxy)aniline; 4-(benzyloxy)phenylamine | C13H13NO | 详情 | 详情 | |
| (VIII) | 38230 | tert-butyl 4-[4-(benzyloxy)anilino]-1-piperidinecarboxylate | C23H30N2O3 | 详情 | 详情 | |
| (IX) | 12989 | 4-Bromo-2-methyl-2-butene; 1-Bromo-3-methyl-2-butene | 870-63-3 | C5H9Br | 详情 | 详情 |
| (X) | 38231 | tert-butyl 4-[4-(benzyloxy)(3-methyl-2-butenyl)anilino]-1-piperidinecarboxylate | C28H38N2O3 | 详情 | 详情 |
合成路线10
该中间体在本合成路线中的序号：(VI)The intermediate chiral aldehyde (XIV) has been obtained as follows: Acylation of sarcosine methyl ester (II) with 3,5-dichlorobenzoyl chloride (I) provides the N-benzoyl aminoester (III). The dilithium derivative of 3,4-dichlorophenylacetic acid (IV) is condensed with ester (III) to furnish, after acidic work-up, the N-benzoyl amino ketone (V). Subsequent alkylation of (V) with 1-bromo-3-methyl-2-butene (VI) affords (VII). Treatment of ketone (VII) with hydroxylamine yields a mixture of E- and Z- oximes, from which the Z-isomer (VIII) is isolated by column chromatography. Resolution of racemic (VIII) is then accomplished by two procedures. Coupling of (VIII) with N-Boc-D-phenylglycine (IX) produces a diastereomeric mixture of O-acyl oximes, from which isomer (X) can be separated by recrystallization. Hydrazinolysis of the N-acyl oxime (X) furnishes the target (R)-enantiomer (XI). Alternatively, oxime (VIII) is acylated by pivaloyl chloride, and subsequently separated into enantiomers by means of chiral chromatography. The desired isomer (XII) is then subjected to hydrazinolysis, yielding (XI)
| 【1】 Carruthers, N.I.; Alaimo, C.A.; Shih, N.-Y.; Lavey, B.J.; Ting, P.C.; Reichard, G.A. (Schering Corp.); Substd. oximes as neurokinin antagonists. EP 1032561; WO 9926924 . |
| 【2】 Carruthers, N.I.; Reichard, G.A.; Shih, N.-Y.; Lavey, B.J.; Alaimo, C.A.; Ting, P.C. (Schering Corp.); Substd. oximes as neurokinin antagonists. US 6063926 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 27769 | 3,5-dichlorobenzoyl chloride | 2905-62-6 | C7H3Cl3O | 详情 | 详情 |
| (II) | 10430 | methyl 2-(methylamino)acetate; methyl N-methylglycinate | 5473-12-1 | C4H9NO2 | 详情 | 详情 |
| (III) | 44268 | methyl 2-[(3,5-dichlorobenzoyl)(methyl)amino]acetate | C11H11Cl2NO3 | 详情 | 详情 | |
| (IV) | 30414 | 2-(3,4-dichlorophenyl)acetic acid；2-(3,4-Dichlorophenyl)acetic acid | 5807-30-7 | C8H6Cl2O2 | 详情 | 详情 |
| (V) | 44269 | 3,5-dichloro-N-[3-(3,4-dichlorophenyl)-2-oxopropyl]-N-methylbenzamide | C17H13Cl4NO2 | 详情 | 详情 | |
| (VI) | 12989 | 4-Bromo-2-methyl-2-butene; 1-Bromo-3-methyl-2-butene | 870-63-3 | C5H9Br | 详情 | 详情 |
| (VII) | 44270 | 3,5-dichloro-N-[3-(3,4-dichlorophenyl)-6-methyl-2-oxo-5-heptenyl]-N-methylbenzamide | C22H21Cl4NO2 | 详情 | 详情 | |
| (VIII) | 44271 | 3,5-dichloro-N-[3-(3,4-dichlorophenyl)-2-(hydroxyimino)-6-methyl-5-heptenyl]-N-methylbenzamide | C22H22Cl4N2O2 | 详情 | 详情 | |
| (IX) | 61344 | BOC-D-alpha-phenylglycine | 33125-05-2 | C13H17NO4 | 详情 | 详情 |
| (X) | 61345 | 3,5-dichloro-N-{(Z,6R)-2-[(1R)-1-(3,4-dichlorophenyl)-4-methyl-3-pentenyl]-8-hydroxy-10,10-dimethyl-5-oxo-6-phenyl-4,9-dioxa-3,7-diaza-2-undecen-1-yl}-N-methylbenzamide | C35H39Cl4N3O5 | 详情 | 详情 | |
| (XI) | 44273 | 3,5-dichloro-N-[(3R)-3-(3,4-dichlorophenyl)-2-(hydroxyimino)-6-methyl-5-heptenyl]-N-methylbenzamide | C22H22Cl4N2O2 | 详情 | 详情 | |
| (XII) | 61346 | 3,5-dichloro-N-((3R)-3-(3,4-dichlorophenyl)-2-{[(2,2-dimethylpropanoyl)oxy]imino}-6-methyl-5-heptenyl)-N-methylbenzamide | C27H30Cl4N2O3 | 详情 | 详情 |
合成路线11
该中间体在本合成路线中的序号：(IV)Reductive condensation of N-Boc-4-piperidone (I) with 4-(benzyloxy)aniline (II) in the presence of NaBH(OAc)3 produced the secondary amine (III), which was further alkylated with 4-bromo-2-methyl-2-butene (IV) to afford the tertiary amine (V). Subsequent acid cleavage of the Boc protecting group of (V) furnished the intermediate piperidine (VI).
| 【1】 Ryder, T.R.; Rafferty, M.F.; Hu, L.-Y. (Pfizer Inc.); Heterocyclic substd. aniline calcium channel blockers. US 6251919; WO 9943658 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 18620 | tert-butyl 4-oxo-1-piperidinecarboxylate;BOC-Piperidone;N-(tert-Butoxycarbonyl)-4-piperidone; N-Boc-4-piperidone | 79099-07-3 | C10H17NO3 | 详情 | 详情 |
| (II) | 22460 | 4-(benzyloxy)aniline; 4-(benzyloxy)phenylamine | C13H13NO | 详情 | 详情 | |
| (III) | 38230 | tert-butyl 4-[4-(benzyloxy)anilino]-1-piperidinecarboxylate | C23H30N2O3 | 详情 | 详情 | |
| (IV) | 12989 | 4-Bromo-2-methyl-2-butene; 1-Bromo-3-methyl-2-butene | 870-63-3 | C5H9Br | 详情 | 详情 |
| (V) | 38231 | tert-butyl 4-[4-(benzyloxy)(3-methyl-2-butenyl)anilino]-1-piperidinecarboxylate | C28H38N2O3 | 详情 | 详情 | |
| (VI) | 38232 | N-[4-(benzyloxy)phenyl]-N-(3-methyl-2-butenyl)-N-(4-piperidinyl)amine; N-[4-(benzyloxy)phenyl]-N-(3-methyl-2-butenyl)-4-piperidinamine | C23H30N2O | 详情 | 详情 |
合成路线12
该中间体在本合成路线中的序号：(VI)Acylation of sarcosine methyl ester (I) with 3,5-dichlorobenzoyl chloride (II) produced the corresponding amide (III). Claisen condensation of (III) with the dianion of 3,4-dichlorophenylacetic acid (IV), generated in the presence of lithium hexamethyldisilazide, gave, after acid decarboxylation, ketone (V). The lithium enolate of ketone (V) was then alkylated with 1-bromo-3-methyl-2-butene (VI) to afford (VII). Treatment of ketone (VII) with hydroxylamine produced a geometric mixture of oximes from which the desired (E)-isomer (VIII) was isolated by column chromatography. Resolution of the racemic (VIII) was achieved by coupling with N-Boc-D-phenylglycine (IX) followed by fractional crystallization of the desired diastereoisomer (X). Hydrazinolysis of the oxime ester then furnished the chiral intermediate (XI).
| 【1】 Carruthers, N.I.; Alaimo, C.A.; Shih, N.-Y.; Lavey, B.J.; Ting, P.C.; Reichard, G.A. (Schering Corp.); Substd. oximes as neurokinin antagonists. EP 1032561; WO 9926924 . |
| 【2】 Carruthers, N.I.; Reichard, G.A.; Shih, N.-Y.; Lavey, B.J.; Alaimo, C.A.; Ting, P.C. (Schering Corp.); Substd. oximes as neurokinin antagonists. US 6063926 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 10430 | methyl 2-(methylamino)acetate; methyl N-methylglycinate | 5473-12-1 | C4H9NO2 | 详情 | 详情 |
| (II) | 27769 | 3,5-dichlorobenzoyl chloride | 2905-62-6 | C7H3Cl3O | 详情 | 详情 |
| (III) | 44268 | methyl 2-[(3,5-dichlorobenzoyl)(methyl)amino]acetate | C11H11Cl2NO3 | 详情 | 详情 | |
| (IV) | 30414 | 2-(3,4-dichlorophenyl)acetic acid；2-(3,4-Dichlorophenyl)acetic acid | 5807-30-7 | C8H6Cl2O2 | 详情 | 详情 |
| (V) | 44269 | 3,5-dichloro-N-[3-(3,4-dichlorophenyl)-2-oxopropyl]-N-methylbenzamide | C17H13Cl4NO2 | 详情 | 详情 | |
| (VI) | 12989 | 4-Bromo-2-methyl-2-butene; 1-Bromo-3-methyl-2-butene | 870-63-3 | C5H9Br | 详情 | 详情 |
| (VII) | 44270 | 3,5-dichloro-N-[3-(3,4-dichlorophenyl)-6-methyl-2-oxo-5-heptenyl]-N-methylbenzamide | C22H21Cl4NO2 | 详情 | 详情 | |
| (VIII) | 44271 | 3,5-dichloro-N-[3-(3,4-dichlorophenyl)-2-(hydroxyimino)-6-methyl-5-heptenyl]-N-methylbenzamide | C22H22Cl4N2O2 | 详情 | 详情 | |
| (IX) | 22613 | (2R)-2-[(tert-butoxycarbonyl)amino]-2-phenylethanoic acid | 2900-27-8 | C13H17NO4 | 详情 | 详情 |
| (X) | 44272 | tert-butyl (1R)-2-([[(Z,2R)-1-[[(3,5-dichlorobenzoyl)(methyl)amino]methyl]-2-(3,4-dichlorophenyl)-5-methyl-4-hexenylidene]amino]oxy)-2-oxo-1-phenylethylcarbamate | C35H37Cl4N3O5 | 详情 | 详情 | |
| (XI) | 44273 | 3,5-dichloro-N-[(3R)-3-(3,4-dichlorophenyl)-2-(hydroxyimino)-6-methyl-5-heptenyl]-N-methylbenzamide | C22H22Cl4N2O2 | 详情 | 详情 |
合成路线13
该中间体在本合成路线中的序号：(II)Alkylation of chrysin (I) with prenyl bromide (II) in the presence of K2CO3 in acetone provided 7-O-(3,3-dimethylallyl)chrysin (III). Claisen rearrangement of (III) in the presence of NaOAc in refluxing Ac2O gave rise to the 8-(1,1-dimethylallyl) flavone (IV) and minor amounts of the desired 8-(3,3-dimethylallyl) analogue (V). Saponification of the mixture of acetate esters, followed by chromatographic separation, furnished the title 8-(3,3-dimethylallyl)chrysin.
| 【1】 Mariotte, A.-M.; Barron, D.; Syntheses of 8-C-(1,1-dimethylallyl) flavones and 3-methyl flavonols. Nat Prod Lett 1994, 4, 1, 21. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 47707 | 5,7-Dihydroxyflavone; Chrysin; Chrysine; 5,7-dihydroxy-2-phenyl-4H-chromen-4-one | 480-40-0 | C15H10O4 | 详情 | 详情 |
| (II) | 12989 | 4-Bromo-2-methyl-2-butene; 1-Bromo-3-methyl-2-butene | 870-63-3 | C5H9Br | 详情 | 详情 |
| (III) | 47708 | 5-hydroxy-7-[(3-methyl-2-butenyl)oxy]-2-phenyl-4H-chromen-4-one | C20H18O4 | 详情 | 详情 | |
| (IV) | 47709 | 5-(acetoxy)-8-(1,1-dimethyl-2-propenyl)-4-oxo-2-phenyl-4H-chromen-7-yl acetate | C24H22O6 | 详情 | 详情 | |
| (V) | 47710 | 5-(acetoxy)-8-(3-methyl-2-butenyl)-4-oxo-2-phenyl-4H-chromen-7-yl acetate | C24H22O6 | 详情 | 详情 |
合成路线14
该中间体在本合成路线中的序号：(II)In an improved procedure, chrysin (I) was alkylated with prenyl bromide (II) under phase-transfer conditions, and the resulting prenyl ether (III) was subsequently rearranged under microwave irradiation to produce a mixture of the title compound as the major product along with the 6-prenyl (VI) and the 6,8-diprenyl (VII) derivatives, which were separated by column chromatography.
| 【1】 Conseil, G.; Daskiewicz, J.-B.; Bayet, C.; Viornery-Vanier, A.; Dmontet, C.; Di Pietro, A.; Comte, G.; Barron, D.; C-Isoprenylation of flavonoids enhances binding affinity toward P-glycoprotein and modulation of cancer cell chemoresistance. J Med Chem 2001, 44, 5, 763. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 47707 | 5,7-Dihydroxyflavone; Chrysin; Chrysine; 5,7-dihydroxy-2-phenyl-4H-chromen-4-one | 480-40-0 | C15H10O4 | 详情 | 详情 |
| (II) | 12989 | 4-Bromo-2-methyl-2-butene; 1-Bromo-3-methyl-2-butene | 870-63-3 | C5H9Br | 详情 | 详情 |
| (III) | 47708 | 5-hydroxy-7-[(3-methyl-2-butenyl)oxy]-2-phenyl-4H-chromen-4-one | C20H18O4 | 详情 | 详情 | |
| (VI) | 47711 | 5,7-dihydroxy-6-(3-methyl-2-butenyl)-2-phenyl-4H-chromen-4-one | C20H18O4 | 详情 | 详情 | |
| (VII) | 47712 | 5,7-dihydroxy-6,8-bis(3-methyl-2-butenyl)-2-phenyl-4H-chromen-4-one | C25H26O4 | 详情 | 详情 |